
View larger version (95K):
[in a new window]
|
Fig. 6. Loss of pax2.1 expression in embryos treated with an inhibitor of Fgfr signalling. Embryos were treated with either DMSO (A-C,G-I) or SU5402 (D-F,J-L) for 5 hours between 30% epiboly and tailbud (A,D,G,J), 60% epiboly and 2-3 somite (B,E,H,K), or 5-somite and 16-somite stages (C,F,I,L). Embryos were either fixed immediately and hybridised for erm transcripts (A-F) or allowed to develop until 16 somites and then hybridised for pax2.1 (G-L). (A-F) erm transcripts are reduced or abrogated in the otic region and hindbrain (brackets in A and D, arrows in B,C,E,F). (G-L) pax2.1 transcripts (arrows) are absent in embryos exposed to inhibitor at early stages (G,H,J,K) but not at later stages (I,L).
|